Enhancing Phase 1 Clinical Trials with Point-of-Need Safety Assessments

Syneos Health, a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success, encountered an obstacle during a Phase 1 study. The study protocol required monitoring for potential ocular side effects, but the clinic lacked the specialized equipment and personnel to conduct comprehensive eye exams.

To address this specific need, 20/20 Onsite deployed the Mobile Clinical Suite (MCS) at the Syneos Health Miami Phase 1 Unit. This customized exam room, complete with advanced equipment and experienced staff, enabled comprehensive eye assessments without patients needing to travel off-site. The MCS facilitated convenient participation, maintained data integrity, and provided Syneos Health access to 20/20 Onsite's expertise in ophthalmological clinical trial protocols.

• Slit-lamp Examination
• Retinal Imaging
• Direct/indirect Ophthalmoscopy
• Visual Field
• Near Vision J Reading

Syneos Health avoided significant investment in equipment and staffing while gaining access to specialized resources, and the study became more cost-effective for the sponsor as well.

Onsite eye assessments ensured patients received high-quality care within the familiar clinic environment while seamlessly integrating into the clinic workflow providing a smooth patient experience.

Our MCS provided the missing link necessary to take on this Phase 1 clinical trial. The collaboration also opened new doors for Syneos Health, whose team previously had challenging experiences dealing with off-site eye assessments. 

Building on this success, Syneos Health and 20/20 Onsite are collaborating on additional Phase 1 trials, further showcasing the adaptability and impact of the MCS in diverse clinical research settings. Visit our website or contact us today to schedule a consultation and explore how our point-of-need solutions can support your clinical research!